SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-007830
Filing Date
2019-03-14
Accepted
2019-03-14 16:18:03
Documents
95
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K eigr-10k_20181231.htm 10-K 2780072
2 EX-10.37 eigr-ex1037_974.htm EX-10.37 94089
3 EX-10.38 eigr-ex1038_1121.htm EX-10.38 105892
4 EX-21.1 eigr-ex211_7.htm EX-21.1 6088
5 EX-23.1 eigr-ex231_6.htm EX-23.1 3262
6 EX-31.1 eigr-ex311_8.htm EX-31.1 16518
7 EX-31.2 eigr-ex312_12.htm EX-31.2 16891
8 EX-32.1 eigr-ex321_11.htm EX-32.1 10622
9 GRAPHIC gf2mfuq10cbu000002.jpg GRAPHIC 20233
10 GRAPHIC gf2mfuq10cbu000005.jpg GRAPHIC 15162
11 GRAPHIC gf2mfuq10cbu000007.jpg GRAPHIC 19600
12 GRAPHIC gf2mfuq10cbu000004.jpg GRAPHIC 36208
13 GRAPHIC gf2mfuq10cbu000003.jpg GRAPHIC 27637
14 GRAPHIC gf2mfuq10cbu000001.jpg GRAPHIC 39302
15 GRAPHIC gf2mfuq10cbu000008.jpg GRAPHIC 17018
16 GRAPHIC gf2mfuq10cbu000006.jpg GRAPHIC 13465
  Complete submission text file 0001564590-19-007830.txt   9828937

Data Files

Seq Description Document Type Size
17 XBRL INSTANCE DOCUMENT eigr-20181231.xml EX-101.INS 1798703
18 XBRL TAXONOMY EXTENSION SCHEMA eigr-20181231.xsd EX-101.SCH 81947
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20181231_cal.xml EX-101.CAL 62788
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20181231_def.xml EX-101.DEF 306763
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20181231_lab.xml EX-101.LAB 599867
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20181231_pre.xml EX-101.PRE 464292
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36183 | Film No.: 19681300
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1